Becker Capital Management Inc Baxter International Inc Transaction History

Becker Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$39.98 - $47.68 $180,949 - $215,799	4,526 New	4,526 $206,000
Q2 2022 Aug 04, 2022	SELL	$63.83 - $80.0 $4,276 - $5,360	-67 Reduced 1.46%	4,526 $291,000
Q1 2022 May 12, 2022	SELL	$76.85 - $89.45 $5,072 - $5,903	-66 Reduced 1.42%	4,593 $356,000
Q4 2021 Feb 08, 2022	SELL	$74.57 - $87.19 $21,550 - $25,197	-289 Reduced 5.84%	4,659 $400,000
Q3 2021 Oct 14, 2021	SELL	$73.77 - $83.61 $4,942 - $5,601	-67 Reduced 1.34%	4,948 $398,000
Q2 2021 Aug 12, 2021	BUY	$80.5 - $88.01 $23,264 - $25,434	289 Added 6.12%	5,015 $404,000
Q4 2020 Feb 10, 2021	SELL	$75.39 - $82.36 $4,523 - $4,941	-60 Reduced 1.25%	4,726 $379,000
Q3 2020 Nov 09, 2020	BUY	$78.33 - $90.73 $4,699 - $5,443	60 Added 1.27%	4,786 $385,000
Q1 2019 May 08, 2019	BUY	$64.48 - $81.31 $9,672 - $12,196	150 Added 3.28%	4,726 $384,000
Q1 2018 May 07, 2018	BUY	$62.56 - $72.26 $286,274 - $330,661	4,576 New	4,576 $298,000

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Becker Capital Management Inc with notifications on news.